Literature DB >> 22123891

QTc values among children and adolescents presenting to the emergency department.

Charlotte S Van Dorn1, Jonathan N Johnson, Nathaniel W Taggart, Lois Thorkelson, Michael J Ackerman.   

Abstract

OBJECTIVE: Long-QT syndrome (LQTS) is both underdiagnosed and overdiagnosed. Many patients are incorrectly diagnosed as having LQTS after presenting to an emergency department (ED) with presyncope/syncope and demonstrating "borderline" QT-interval prolongation (QTc ≥ 440 milliseconds) in a sentinel ED-obtained electrocardiogram (ECG). We sought to evaluate the distribution and clinical significance of QT intervals in the ED.
METHODS: We retrospectively reviewed data for all patients 22 years of age or younger (N = 626; 369 females; age, mean ± SD: 17 ± 5 years) who had ECGs obtained in our ED between July 1, 2007, and June 30, 2008. A total of 223 patients were excluded because of known structural heart disease, arrhythmias, electrolyte abnormalities, or exposure to QT-interval-prolonging medications.
RESULTS: The average QTc was 428 ± 28 milliseconds (range: 344-566 milliseconds), and approximately one-third of patients had QTc values of ≥440 milliseconds (females: 41%; males: 21%). Overall, 104 patients presented with presyncope/syncope, of whom 14 (13%) had follow-up ECGs. On follow-up, these patients demonstrated significant decreases in QTc values of 33 ± 43 milliseconds (P < .04). Only 8 (31%) of 26 patients with presyncope/syncope with borderline QT values had follow-up ECGs performed, in 5 of which the QTc values were decreased significantly. No patients ultimately received LQTS diagnoses.
CONCLUSIONS: In the ED setting, approximately one-third of pediatric patients exhibited QTc values of ≥440 milliseconds and had significant normalization of QTc values in follow-up evaluations. First-time ECGs obtained after a syncopal episode must be interpreted with caution, particularly in the context of so-called borderline QT intervals.

Entities:  

Mesh:

Year:  2011        PMID: 22123891     DOI: 10.1542/peds.2010-1513

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Phenotype of Children with QT Prolongation Identified Using an Institution-Wide QT Alert System.

Authors:  Heather N Anderson; J Martijn Bos; Kristina H Haugaa; Bruce W Morlan; Robert F Tarrell; Pedro J Caraballo; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2015-04-07       Impact factor: 1.655

2.  Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.

Authors:  B R Moore; J M Benjamin; S Salman; S Griffin; E Ginny; M Page-Sharp; L J Robinson; P Siba; K T Batty; I Mueller; T M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

Review 3.  Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality.

Authors:  Koyelle Papneja; Anthony K Chan; Tapas K Mondal; Bosco Paes
Journal:  Pediatr Cardiol       Date:  2017-02-25       Impact factor: 1.655

4.  Evaluation of QTc in Rett syndrome: Correlation with age, severity, and genotype.

Authors:  Jane Crosson; Siddharth Srivastava; Genila M Bibat; Siddharth Gupta; Aditi Kantipuly; Constance Smith-Hicks; Scott M Myers; Abanti Sanyal; Gayane Yenokyan; Joel Brenner; Sakkubai R Naidu
Journal:  Am J Med Genet A       Date:  2017-04-10       Impact factor: 2.802

5.  Effects of Methadone on Corrected Q-T Interval Prolongation in Critically Ill Children.

Authors:  Travis S Heath; Rachel G Greenberg; Susan R Hupp; David A Turner; Christoph P Hornik; Kanecia O Zimmerman
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

6.  Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study.

Authors:  John Benjamin; Brioni Moore; Sook Ting Lee; Michèle Senn; Susan Griffin; Dulci Lautu; Sam Salman; Peter Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

7.  Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.

Authors:  Moses Laman; Brioni R Moore; John M Benjamin; Gumul Yadi; Cathy Bona; Jonathan Warrel; Johanna H Kattenberg; Tamarah Koleala; Laurens Manning; Bernadine Kasian; Leanne J Robinson; Naomi Sambale; Lina Lorry; Stephan Karl; Wendy A Davis; Anna Rosanas-Urgell; Ivo Mueller; Peter M Siba; Inoni Betuela; Timothy M E Davis
Journal:  PLoS Med       Date:  2014-12-30       Impact factor: 11.069

8.  Bradycardia and Hypothermia Complicating Azithromycin Treatment.

Authors:  Kerri Benn; Sam Salman; Madhu Page-Sharp; Timothy M E Davis; Jim P Buttery
Journal:  Am J Case Rep       Date:  2017-08-11

9.  Overt long QT syndrome in children presenting with seizure disorders in Pakistan.

Authors:  Usman Rashid; Ahmad Omair Virk; Rashid Nawaz; Tahir Mahmood; Zile Fatima
Journal:  Ann Pediatr Cardiol       Date:  2022-03-25

10.  QTc prolongation in adolescents with acute alcohol intoxication.

Authors:  Loes de Veld; Nico van der Lely; Ben J M Hermans; Joris J van Hoof; Lichelle Wong; Arja Suzanne Vink
Journal:  Eur J Pediatr       Date:  2022-04-28       Impact factor: 3.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.